-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades GE HealthCare Techs to Neutral, Lowers Price Target to $69

Benzinga·05/21/2026 13:52:29
Listen to the news
UBS analyst Graham Doyle upgrades GE HealthCare Techs (NASDAQ:GEHC) from Sell to Neutral and lowers the price target from $75 to $69.